<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48-viruses-11-00365">
 <label>48.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mazar</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Rosado</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Phelan</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kedarinath</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Parks</surname>
    <given-names>G.D.</given-names>
   </name>
   <name>
    <surname>Alexander</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Westmoreland</surname>
    <given-names>T.J.</given-names>
   </name>
  </person-group>
  <article-title>Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24</article-title>
  <source>PLoS ONE</source>
  <year>2018</year>
  <volume>13</volume>
  <elocation-id>e0200358</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0200358</pub-id>
  <pub-id pub-id-type="pmid">30044847</pub-id>
 </element-citation>
</ref>
